While our study demonstrated that combination therapy showed broad benefits in reducing the risks of mortality, MAKE, and MALO, we found no significant difference in MACE risk between the GLP-1RA plus SGLT2i group and SGLT2i monotherapy group (HR, 1.1
The Role of Ferroptosis in Diabetes Pathogenesis: Therapeutic Implications of Hydrogen Sulfide and Its Reactive Metabolites Vesna Otasevic et al
Three phases of detoxification:[ref] Phase I (bioactivation transformation) involves breaking apart large toxins and converting them into polar molecules
Mima A, Nomura A, Fujii T
W., Redpath, P., Zhan, L., Chellappa, K., White, E., Migaud, M., Mitchison, T
Furthermore, the rise of biologic drugs and other injectable diabetes medications, along with the increasing number of diabetes-related complications, is driving the greater use of intravenous treatments in hospitals and clinics